SORBUGEN NR recalled over manufacturing violations

Recall date

June 21, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Pharma-Natural Inc. recalls SORBUGEN NR (Dextromethorphan HBr, 15 mg; Glyceryl Guaiacolate (Guaifenesin), 150 mg) in each 7.5 mL 1 1/2 tsp), GRAPE…

Recall number

D-1505-2019

FDA classification

Class II

Brand / firm

Pharma-Natural Inc.

Sold / distributed

Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.

Why it was recalled

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

SORBUGEN NR (Dextromethorphan HBr, 15 mg; Glyceryl Guaiacolate (Guaifenesin), 150 mg) in each 7.5 mL 1 1/2 tsp), GRAPE FLAVOR, 16 Fl.oz. (473 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-660-16.